RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City

MLA

Hernandez, Matthew M., et al. “RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City.” The Journal of Molecular Diagnostics, vol. 24, no. 7, July 2022, pp. 738–49. EBSCOhost, https://doi.org/10.1016/j.jmoldx.2022.04.003.

APA

Hernandez, M. M., Banu, R., Gonzalez-Reiche, A. S., Gray, B., Shrestha, P., Cao, L., Chen, F., Shi, H., Hanna, A., Ramírez, J. D., van de Guchte, A., Sebra, R., Gitman, M. R., Nowak, M. D., Cordon-Cardo, C., Schutzbank, T. E., Simon, V., van Bakel, H., Sordillo, E. M., & Paniz-Mondolfi, A. E. (2022). RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City. The Journal of Molecular Diagnostics, 24(7), 738–749. https://doi.org/10.1016/j.jmoldx.2022.04.003

Chicago

Hernandez, Matthew M., Radhika Banu, Ana S. Gonzalez-Reiche, Brandon Gray, Paras Shrestha, Liyong Cao, Feng Chen, et al. 2022. “RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City.” The Journal of Molecular Diagnostics 24 (7): 738–49. doi:10.1016/j.jmoldx.2022.04.003.